IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+12.69%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$269M
AUM Growth
+$269M
Cap. Flow
+$20.3M
Cap. Flow %
7.54%
Top 10 Hldgs %
54.13%
Holding
130
New
23
Increased
25
Reduced
23
Closed
23

Top Buys

1
SLNO icon
Soleno Therapeutics
SLNO
$15.8M
2
RCKT icon
Rocket Pharmaceuticals
RCKT
$13.4M
3
IMVT icon
Immunovant
IMVT
$11.4M
4
AKRO icon
Akero Therapeutics
AKRO
$10.1M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
$9.45M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$12.2M
2
MRK icon
Merck
MRK
$11.5M
3
BHVN icon
Biohaven
BHVN
$8.36M
4
INSM icon
Insmed
INSM
$8.34M
5
IDYA icon
IDEAYA Biosciences
IDYA
$7.39M

Sector Composition

1 Healthcare 97.77%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FNCH
76
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$35.1K ﹤0.01%
6,892
-1,025
-13% -$5.23K
ROIV icon
77
Roivant Sciences
ROIV
$8.6B
$21.3K ﹤0.01%
1,821
-223,179
-99% -$2.61M
BCLI
78
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$18.1K ﹤0.01%
6,016
-6,646
-52% -$19.9K
ASLN
79
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$6.22K ﹤0.01%
4,428
-16,083
-78% -$22.6K
FGEN icon
80
FibroGen
FGEN
$48.4M
$2.39K ﹤0.01%
111
-9,026
-99% -$195K
PHXM
81
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$1.56K ﹤0.01%
301
-1
-0.3% -$5
AZN icon
82
AstraZeneca
AZN
$255B
– –
0
– –
BCYC
83
Bicycle Therapeutics
BCYC
$492M
– –
-203,037
Closed -$5.18M
BLUE
84
DELISTED
bluebird bio
BLUE
– –
-20,631
Closed -$1.36M
BMEA icon
85
Biomea Fusion
BMEA
$114M
– –
-275,875
Closed -$6.06M
BMRN icon
86
BioMarin Pharmaceuticals
BMRN
$11.3B
– –
0
– –
VERV
87
DELISTED
Verve Therapeutics
VERV
– –
0
– –
ABBV icon
88
AbbVie
ABBV
$374B
– –
0
– –
ACRS icon
89
Aclaris Therapeutics
ACRS
$223M
– –
-200,163
Closed -$2.08M
AMLX icon
90
Amylyx Pharmaceuticals
AMLX
$877M
– –
0
– –
APLS icon
91
Apellis Pharmaceuticals
APLS
$3.51B
– –
-133,800
Closed -$12.2M
ARDX icon
92
Ardelyx
ARDX
$1.57B
– –
-278,825
Closed -$945K
ARGX icon
93
argenx
ARGX
$44.2B
– –
0
– –
ARWR icon
94
Arrowhead Research
ARWR
$3.84B
– –
-130,000
Closed -$4.64M
ASND icon
95
Ascendis Pharma
ASND
$12.1B
– –
-2,090
Closed -$187K
CLDX icon
96
Celldex Therapeutics
CLDX
$1.57B
– –
0
– –
CNTB
97
Connect Biopharma
CNTB
$111M
– –
-219,501
Closed -$244K
CYTK icon
98
Cytokinetics
CYTK
$5.98B
– –
0
– –
DYN icon
99
Dyne Therapeutics
DYN
$1.92B
– –
0
– –
ELDN icon
100
Eledon Pharmaceuticals
ELDN
$155M
– –
-221,830
Closed -$304K
2 3
4
5 6